Peutz Jeghers Syndrome

Peutz-Jeghers syndrome (PJS) is a rare inherited condition characterized by hamartomatous polyps in the gastrointestinal tract and distinctive dark pigmented spots on the lips, mouth, fingers, or other mucocutaneous areas. Although it is uncommon, it is clinically important because it increases the risk of bowel complications and several cancers over time. ^[1][2]

What is Peutz-Jeghers syndrome?

PJS is an inherited syndrome, most often associated with pathogenic changes in the STK11 gene. It is typically passed in an autosomal dominant pattern, although some individuals have no known family history. The syndrome is not defined by one polyp alone; it is a systemic predisposition involving characteristic pigmentation, hamartomatous polyps, and long-term cancer risk. Because many of the associated problems can be silent for years, the condition requires structured lifelong follow-up rather than symptom-based care alone. ^[1][2][3]

What symptoms can occur?

Some people are first recognized because of dark blue-brown or black pigmented spots around the lips, inside the mouth, or on the fingers. Others present with abdominal pain, anemia, gastrointestinal bleeding, bowel obstruction, or intussusception caused by polyps. Nausea, vomiting, or recurrent unexplained abdominal complaints may also occur. In some patients the syndrome is identified only after family screening or evaluation for polyps. The presentation therefore varies widely according to age, polyp burden, and whether complications have already developed. ^[1][2][4]

Why is it important?

PJS matters not only because of the polyps but also because it is associated with increased lifetime risk of several malignancies, including gastrointestinal, pancreatic, breast, gynecologic, and other cancers. It can also lead to acute bowel complications, especially intussusception. The condition is therefore relevant in both preventive and acute-care settings. Early recognition makes it possible to reduce risk through surveillance and timely treatment of complications. ^[1][2][5]

How is the diagnosis made?

Diagnosis is based on a combination of clinical findings, family history, endoscopic findings, pathology of hamartomatous polyps, and genetic evaluation when appropriate. The presence of characteristic mucocutaneous pigmentation and multiple compatible polyps strongly raises suspicion. Because some people first come to attention after a complication such as intussusception or bleeding, diagnosis may emerge during emergency or gastroenterology evaluation. The diagnostic process also has implications for relatives, who may require counseling and testing. ^[1][2][3]

How is follow-up planned?

Follow-up involves structured surveillance tailored to age, symptoms, and family history. Gastrointestinal endoscopy is used to detect and manage polyps, and additional screening is often planned for associated cancer risks. The goal is not simply to “watch the condition,” but to detect complications and malignancy risk as early as possible. Because follow-up often spans multiple organ systems, care may involve gastroenterology, genetics, surgery, oncology, and other specialties. ^[1][2][5]

Which warning signs should not be ignored?

Severe abdominal pain, vomiting, abdominal distention, bloody stools, unexplained anemia, or signs of bowel obstruction require prompt evaluation. New or unusual symptoms in a person with known PJS should not be assumed to be minor. Likewise, relatives of an affected person should not postpone appropriate genetic and clinical assessment if recommended. ^[1][2][4]

FAQ

Is Peutz-Jeghers syndrome inherited?
Yes. It is usually inherited in an autosomal dominant pattern, although some cases arise without a known family history. ^[1][2]

Do all patients have visible dark spots?
Not always. Pigmentation can fade with age, and not every person presents in the same way. ^[1][2]

Why are the intestinal polyps important?
They can bleed, cause obstruction, or lead to intussusception. ^[1][2]

Is cancer risk increased?
Yes. PJS is associated with increased lifetime risk of several cancers. ^[1][2]

Why is long-term surveillance necessary?
Because complications and cancer risk may develop over time even when symptoms are minimal. ^[1][2]